Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers
Citation:
Davern, M. and Lysaght, J., Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers, Cancer Letters, 495, 2020, 89-99Download Item:
1-s2.0-S0304383520304778-main.pdf (PDF) 2.433Mb
Abstract:
Gastroesophageal cancers (GOCs) represent some of the most common cancers globally and are linked with poor survival rates. The current standard of care includes multimodal chemotherapy, radiotherapy and surgery. However, up to two-thirds of patients fail to derive benefit from these treatments, underscoring the urgent need to develop better, rationally-designed treatment strategies to enhance survival rates. Certain immunogenic chemotherapies can stimulate anti-tumour immune responses in GOC patients; therefore, combining immune checkpoint inhibitors (ICIs) with chemotherapy to prevent immune exhaustion is an attractive putative therapeutic strategy. Emerging studies demonstrate that immune checkpoint-intrinsic signalling in cancer cells supports several cancer hallmarks in addition to immune evasion, including proliferation, metastasis, glycolysis, DNA repair and chemoresistance. Combining ICIs with chemotherapy may therefore potentially enhance chemosensitivity and suppress a range of immune-dependent and -independent tumourigenic processes in GOCs. This review summarises the current clinical trials investigating the efficacy of ICIs in GOCs. The immunogenic effects of chemotherapies and their effects on immune checkpoint expression is discussed, as is the important and emerging study of novel immune-independent functions of immune checkpoints in cancer.
Author's Homepage:
http://people.tcd.ie/jlysaghtDescription:
PUBLISHEDcited By 1
Author: Lysaght, Joanne
Type of material:
Journal ArticleCollections:
Series/Report no:
Cancer Letters495
Availability:
Full text availableKeywords:
cancer cells, immune checkpoint blockade (ICB), Gastroesophageal cancers (GOCs), Chemotherapy, Gastric cancer, Immune checkpoint inhibitors (ICIs), Immunotherapy combinations, Oesophageal cancerDOI:
http://dx.doi.org/10.1016/j.canlet.2020.09.014Licences:
Related items
Showing items related by title, author, creator and subject.
-
Establishing a Community Focused Approach to Cancer Prevention in Cork City North West (Fairhill, Farranree and Guarranabraher) : A report undertaken on behalf of the Cork Cancer Action Network and facilitated by the Irish Cancer Society
Irish Cancer Society; Cork Cancer Action Network (Cork Cancer Action Network / Irish Cancer Society, ireland, 2017-01-31) -
Platelet-cancer Cell Interactions induce PAI-1 Expression in an Ovarian Cancer Cell Line Model: Implications for the Metastasis of Epithelial Ovarian Cancer
Kelly, Tanya Elizabeth (Trinity College Dublin. School of Medicine. Discipline of Histopathology, 2021)This thesis encompasses an investigation into the function of plasminogen activator inhibitor 1 (PAI-1) - a serine protease inhibitor integral to coagulation and fibrinolysis that has been identified as both a key factor ... -
Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery
VOLKOV, YURI (2015)Introduction Tumor cells can effectively be killed by heat, e.g. by using magnetic hyperthermia. The main challenge in the field, however, is the generation of therapeutic temperatures selectively in the whole tumor ...